What Makes GIP + GLP-1 Dual Action More Effective for Filipinos?

What Makes GIP + GLP-1 Dual Action More Effective for Filipinos?

When it comes to medically guided weight loss, not all injectables are created equal. While medications like Ozempic have focused on the GLP-1 hormone alone, Verfora™ stands out by combining both GIP and GLP-1 receptor activation—a dual-action mechanism proven to deliver better metabolic results. But why does this matter especially for Filipinos?

Let’s explore how this dual hormone approach works and why it’s particularly effective in the Philippine setting. 

What Are GIP and GLP-1?

GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are natural hormones that help regulate:

  • Blood sugar levels
  • Appetite
  • Insulin sensitivity
  • Fat storage

Traditional GLP-1 drugs like semaglutide (Ozempic) mimic only one of these hormones. But tirzepatide, the active ingredient in Verfora™, mimics both—delivering a synergistic effect that changes how the body handles food, fat, and hunger.

 

Why Is Dual Action More Effective?

By combining GIP and GLP-1, Verfora™ offers:

✅ Stronger Appetite Suppression
✅ More Balanced Blood Sugar Regulation
✅ Better Fat Metabolism
✅ Reduced Cravings—Especially for Carbs & Sweets
✅ Improved Energy Efficiency

This dual approach results in faster, deeper, and more sustainable fat loss compared to single-hormone treatments.

 

Why It Works Especially Well for Filipinos

The Filipino lifestyle and diet often include:

  • High rice and carbohydrate intake
  • Frequent fried and sugary foods
  • Low physical activity (especially for urban professionals)
  • High rates of pre-diabetes, PCOS, and metabolic syndrome

Verfora’s dual-hormone action works with the Filipino body’s tendencies by:

  • Curbing rice and sugar cravings more effectively
  • Helping regulate post-meal blood sugar spikes
  • Encouraging sustained fat loss despite carb-heavy diets
  • Supporting hormonal conditions common in Filipinas (like PCOS)
  • Making weight loss easier without extreme calorie restrictions

 

Clinical Support Behind Dual Agonist Therapy

The SURMOUNT-1 trial and other global studies showed that tirzepatide users lost 15% to 21% of their body weight, outpacing most GLP-1-only treatments.

Participants also experienced:

  • Lower triglycerides and LDL
  • More stable insulin levels
  • Greater reduction in visceral (belly) fat

These results are highly relevant to Filipino patients, who often carry abdominal weight due to insulin resistance.

 

Doctor’s Tip: Lifestyle Still Matters

While Verfora™ makes weight loss easier, lifestyle changes still play a key role:

  • Portion control and meal prepping
  • Substituting white rice with low-GI carbs
  • Increasing fiber and protein
  • Staying hydrated
  • Getting regular movement, even light walking

The dual-hormone advantage simply makes these changes more manageable and effective.

 

Verfora™ is more than just a weight loss medication—it’s a smart, science-backed response to the unique dietary and metabolic challenges faced by many Filipinos. Thanks to the dual power of GIP + GLP-1, your journey to better health no longer needs to feel like an uphill battle.

If you’ve struggled with carb cravings, belly fat, or slow progress despite your efforts, Verfora™ may be the solution your body has been waiting for.

Back to blog